The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Closing the Annual Conference 2023, we would like to thank all our stakeholders for their engagement and support for our shared mission to improve effective cancer treatment and empower patients.

For those interested in our discussion during the last session, “Optimization of Treatment-Dose and Schedule”, here are our take-home messages:


♦ MTD is no longer the holy grail in early studies

♦ Initial randomized optimization studies can be underpowered

♦ Dose discontinuation should be an ultimate part of dose optimization studies

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70